Search

Search Constraints

You searched for: Author/Creator Katus, Hugo A.

Search Results

1. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (November 2019)

2. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA). Issue 1 (29th August 2021)

3. A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy. (15th October 2021)

5. A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk). (15th September 2021)

6. A systematic report on non-coronary cardiac CTA in 1097 patients from the German cardiac CT registry. Issue 130 (September 2020)

7. Addition of copeptin improves diagnostic performance of point-of-care testing (POCT) for cardiac troponin T in early rule-out of myocardial infarction — A pilot study. (1st November 2015)

9. Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis. (27th September 2011)

10. Alterations in cardiac DNA methylation in human dilated cardiomyopathy. Issue 3 (22nd January 2013)